Use of a Fundus Image-Based Titration Strategy for Selective Retina Therapy for Central Serous Chorioretinopathy
Journal of Clinical Medicine · 04.09.2024 · 13 (17) · 5230
DOI: 10.3390/jcm13175230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.09.2024. Verfasst von Seung Hee Jeon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Science, Incheon St. Mary's Hospital, Catholic University of Korea, 56, Dongsu-ro, Bupyeong-gu, Incheon 21431,…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: This study evaluated the clinical outcomes of selective retina therapy (SRT) for treating central serous chorioretinopathy. A fundus image-based titration method was used for laser irradiation.
Methods
This retrospective cohort study included 29 eyes (29 patients) that underwent SRT for CSC. Both the pulse energy and number of micropulses were adjusted according to the fundus image. Mean best-corrected visual acuity (BCVA), central foveal thickness (CFT), and subretinal fluid (SRF) height were measured 1, 2, 3, 4, and 6 months after SRT. Mean deviation (MD) was measured using microperimetry at 3 and 6 months post-treatment.
Results
At 6 months after SRT treatment, SRF was completely resolved in 89.7% of cases (26/29 eyes). The mean Snellen BCVA significantly improved from 0.34 ± 0.31 logMAR (logarithm of the minimum angle of resolution) (20/40) at baseline to 0.24 ± 0.24 logMAR (20/32) at 6 months (p = 0.009). The 0.1 improvement in mean BCVA is equivalent to a 5-letter gain on the ETDRS chart. The mean CFT decreased significantly from 309.31 ± 81.6 μm at baseline to 211.07 ± 50.21 μm at 6 months (p < 0.001). The mean SRF height also decreased significantly from 138.36 ± 56.78 μm at baseline to 23.75 ± 61.19 μm at 6 months (p < 0.001). The mean MD was improved from −1.56 ± 1.47 dB at baseline to −1.03 ± 2.43 dB at 6 months (p = 0.07) after treatment.
Conclusions
SRT using fundus image-based titration can yield favorable functional and anatomical outcomes in the treatment of CSC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Science, Incheon St. Mary's Hospital, Catholic University of Korea, 56, Dongsu-ro, Bupyeong-gu, Incheon 21431, Republic of Korea.
- Department of Ophthalmology and Visual Science, Yeouido St. Mary's Hospital, Catholic University of Korea, 10, 63-ro, Yeongdeungpo-gu, Seoul 07345, Republic of Korea.
- Threshold Co., Ltd., No. 1325, 40, 63-ro, Yeongdeungpo-gu, Seoul 07345, Republic of Korea.
ORCID-Profile: Young-Jung Roh
Zitieren
APA
Jeon, S. H., Kim, M., & Roh, Y. J. (2024). Use of a Fundus Image-Based Titration Strategy for Selective Retina Therapy for Central Serous Chorioretinopathy. Journal of Clinical Medicine, 13(17), 5230. https://doi.org/10.3390/jcm13175230
Vancouver
Jeon SH, Kim M, Roh YJ. Use of a Fundus Image-Based Titration Strategy for Selective Retina Therapy for Central Serous Chorioretinopathy. Journal of Clinical Medicine. 2024;13(17):5230. doi:10.3390/jcm13175230
BibTeX
@article{Jeon2024,
author = {Jeon, Seung Hee and Kim, Minhee and Roh, Young-Jung},
title = {Use of a Fundus Image-Based Titration Strategy for Selective Retina Therapy for Central Serous Chorioretinopathy},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {17},
pages = {5230},
doi = {10.3390/jcm13175230}
}
EUVIMED